Home
Data
Calendar
Blog
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-06-28 | 2020-03-31 | 2020-03-29 | 2019-06-30 | 2019-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Value | 12.10 | 12.10 | 12.10 | 12.10 | 12.10 | 12.10 | 12.10 | 12.10 | NA | NA | 0.00 | NA | 0.00 | NA | NA | |
| Weighted Average Number Of Diluted Shares Outstanding | 1218.10 | 1217.10 | 1213.10 | NA | 1212.60 | 1208.80 | 1207.50 | NA | 517.70 | 517.20 | NA | 517.00 | NA | NA | NA | |
| Weighted Average Number Of Shares Outstanding Basic | 1212.50 | 1212.30 | 1210.50 | NA | 1209.30 | 1208.80 | 1207.50 | NA | 516.90 | 516.90 | NA | 516.40 | 0.00 | NA | 0.00 | |
| Earnings Per Share Basic | 0.29 | 0.26 | 0.33 | -0.22 | 0.26 | -0.23 | -0.86 | -1.59 | 0.36 | 0.08 | NA | 0.04 | 0.00 | NA | 0.00 | |
| Earnings Per Share Diluted | 0.29 | 0.26 | 0.33 | -0.22 | 0.26 | -0.23 | -0.86 | -1.59 | 0.36 | 0.08 | NA | 0.04 | NA | NA | NA |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-06-28 | 2020-03-31 | 2020-03-29 | 2019-06-30 | 2019-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | 4067.40 | 4105.40 | 4178.20 | 4331.30 | 4520.50 | 4561.70 | 4400.10 | 3587.70 | 2948.10 | 2695.90 | 0.00 | 2588.20 | 0.00 | 0.00 | 0.00 | |
| Revenues | 4078.20 | 4116.80 | 4191.70 | 4341.60 | 4536.60 | 4577.80 | 4430.30 | 3623.50 | 2972.10 | 2731.20 | 0.00 | 2619.20 | 0.00 | 0.00 | 0.00 | |
| Cost Of Goods And Services Sold | 2329.80 | 2413.50 | 2420.50 | 2795.20 | 2962.50 | 3250.10 | 3303.00 | 2917.10 | 1813.60 | 1705.50 | NA | 1713.10 | NA | NA | NA | |
| Gross Profit | 1748.40 | 1703.30 | 1771.20 | 1546.40 | 1574.10 | 1327.70 | 1127.30 | 706.40 | 1158.50 | 1025.70 | NA | 906.10 | NA | NA | NA | |
| Operating Expenses | 1188.30 | 1154.60 | 1063.80 | 1624.00 | 1216.50 | 1375.50 | 1393.50 | 1587.50 | 807.10 | 891.50 | 0.00 | 721.40 | 0.00 | 0.00 | 0.00 | |
| Research And Development Expense | 174.90 | 162.60 | 142.30 | 267.20 | 152.10 | 147.70 | 184.10 | 154.80 | 129.80 | 156.30 | NA | 114.20 | NA | NA | NA | |
| Selling General And Administrative Expense | 1017.30 | 981.10 | 915.30 | 1082.90 | 1055.00 | 1204.80 | 1186.50 | 1361.40 | 658.40 | 719.40 | NA | 605.40 | NA | NA | NA | |
| Operating Income Loss | 560.10 | 548.70 | 707.40 | -77.60 | 357.60 | -47.80 | -266.20 | -881.10 | 351.40 | 134.20 | NA | 184.70 | NA | NA | NA | |
| Interest Expense | 153.20 | 145.90 | 146.20 | 148.20 | 151.90 | 167.10 | 169.00 | 421.80 | 117.30 | 116.20 | 5.30 | 119.90 | NA | NA | NA | |
| Income Tax Expense Benefit | 73.20 | 75.40 | 128.30 | 59.90 | -111.60 | 60.10 | 596.30 | 0.70 | 55.90 | -19.40 | -0.30 | 9.90 | 0.00 | 0.00 | 0.00 | |
| Other Comprehensive Income Loss Net Of Tax | -859.90 | -838.20 | -316.70 | -272.40 | -266.90 | 180.60 | -527.60 | 565.80 | 601.10 | 428.60 | 0.00 | -656.30 | 0.00 | 0.00 | 0.00 | |
| Comprehensive Income Net Of Tax | -505.60 | -524.30 | 82.50 | NA | 44.60 | -98.60 | -1565.20 | NA | 786.80 | 468.00 | -0.90 | -635.50 | 0.00 | 0.00 | 0.00 | |
| Net Income Loss Available To Common Stockholders Basic | 354.30 | 313.90 | 399.20 | NA | 311.50 | -279.20 | -1037.60 | NA | 185.70 | 39.40 | NA | 20.80 | NA | NA | NA |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-06-28 | 2020-03-31 | 2020-03-29 | 2019-06-30 | 2019-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | 48662.60 | 51125.10 | 53466.90 | 54842.80 | 56070.40 | 57984.10 | 58979.20 | 61553.00 | NA | NA | 11411.80 | NA | 0.00 | NA | NA | |
| Liabilities | 29480.30 | 31319.70 | 33019.20 | 34350.10 | 34929.10 | 36777.20 | 37564.50 | 38598.90 | NA | NA | 11413.00 | NA | 0.00 | NA | NA | |
| Liabilities And Stockholders Equity | 48662.60 | 51125.10 | 53466.90 | 54842.80 | 56070.40 | 57984.10 | 58979.20 | 61553.00 | NA | NA | 11411.80 | NA | 0.00 | NA | NA |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-06-28 | 2020-03-31 | 2020-03-29 | 2019-06-30 | 2019-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets Current | 10487.80 | 11176.50 | 11744.30 | 10902.90 | 11308.40 | 11749.80 | 12318.50 | 12867.50 | NA | NA | 11411.80 | NA | 0.00 | NA | NA | |
| Cash And Cash Equivalents At Carrying Value | 646.70 | 664.70 | 752.40 | 701.20 | 756.60 | 673.90 | 806.90 | 844.40 | 664.50 | 323.60 | NA | 572.40 | NA | NA | NA | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 650.40 | 669.40 | 757.40 | 706.20 | 761.70 | 679.10 | 813.10 | 850.00 | 667.10 | 324.70 | 0.00 | 587.90 | 0.00 | 0.00 | 0.00 | |
| Accounts Receivable Net Current | 3333.90 | 3736.20 | 4093.90 | 4266.40 | 4345.50 | 4478.70 | 4529.00 | 4843.80 | NA | NA | NA | NA | NA | NA | NA | |
| Receivables Net Current | 2829.80 | 3182.90 | 3556.90 | 3774.40 | 3841.50 | 3880.40 | 3889.60 | 3891.30 | NA | NA | NA | NA | NA | NA | NA | |
| Inventory Net | 3380.40 | 3612.50 | 3797.30 | 3977.70 | 4081.90 | 4487.60 | 4942.20 | 5471.90 | NA | NA | NA | NA | NA | NA | NA | |
| Other Assets Current | 1132.20 | 1145.40 | 1208.10 | 1467.10 | 1652.90 | 1709.60 | 1591.50 | 1236.10 | NA | NA | 0.20 | NA | NA | NA | NA | |
| Prepaid Expense And Other Assets Current | 1700.40 | 1697.70 | 1763.60 | 1957.60 | 2124.40 | 2109.60 | 2040.40 | 1707.40 | NA | NA | NA | NA | NA | NA | NA |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-06-28 | 2020-03-31 | 2020-03-29 | 2019-06-30 | 2019-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Property Plant And Equipment Gross | 5018.60 | 5041.40 | 5092.50 | 5589.10 | 5597.80 | 5663.10 | 5615.70 | 5721.90 | NA | NA | NA | NA | NA | NA | NA | |
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 1979.60 | 1957.50 | 1942.30 | 2400.50 | 2483.80 | 2491.70 | 2368.80 | 2262.00 | NA | NA | NA | NA | NA | NA | NA | |
| Amortization Of Intangible Assets | 615.90 | 634.10 | 648.10 | 664.70 | 671.50 | 681.60 | 684.40 | 534.90 | 368.10 | 351.60 | NA | 351.20 | NA | NA | NA | |
| Property Plant And Equipment Net | 3039.00 | 3083.90 | 3150.20 | 3188.60 | 3114.00 | 3171.40 | 3246.90 | 3459.90 | NA | NA | NA | NA | NA | NA | NA | |
| Goodwill | 10054.60 | 10523.00 | 10978.80 | 12113.70 | 12169.50 | 11990.40 | 11907.30 | 12347.00 | NA | NA | NA | NA | NA | NA | NA | |
| Indefinite Lived Intangible Assets Excluding Goodwill | 42.50 | 43.80 | 45.70 | 46.50 | 79.80 | 79.80 | 80.70 | 80.70 | NA | NA | NA | NA | NA | NA | NA | |
| Intangible Assets Net Excluding Goodwill | 23013.30 | 24101.10 | 25251.80 | 26134.20 | 26987.00 | 27863.70 | 28489.60 | 29683.20 | NA | NA | NA | NA | NA | NA | NA | |
| Finite Lived Intangible Assets Net | 22970.80 | 24057.30 | 25206.10 | 26087.70 | 26907.20 | 27783.90 | 28408.90 | 29602.50 | NA | NA | NA | NA | NA | NA | NA | |
| Other Assets Noncurrent | 963.90 | 997.40 | 1056.00 | 1170.70 | 1039.60 | 1025.10 | 1019.60 | 1047.50 | NA | NA | NA | NA | NA | NA | NA |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-06-28 | 2020-03-31 | 2020-03-29 | 2019-06-30 | 2019-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities Current | 6521.40 | 7681.20 | 9642.90 | 9884.40 | 10103.90 | 10132.60 | 9978.10 | 10562.90 | NA | NA | 27.80 | NA | 0.00 | NA | NA | |
| Debt Current | 755.00 | 758.60 | 2595.40 | 1860.30 | 1881.00 | 2148.40 | 2255.30 | 2256.30 | NA | NA | NA | NA | NA | NA | NA | |
| Long Term Debt Current | 763.80 | 768.20 | 2606.10 | 1877.50 | 1908.10 | 2184.40 | 2300.20 | 2308.50 | NA | NA | NA | NA | NA | NA | NA | |
| Other Accrued Liabilities Current | 1001.40 | 1205.00 | 1388.60 | 1254.60 | 1333.60 | 1280.80 | 1753.20 | 1973.20 | NA | NA | NA | NA | NA | NA | NA | |
| Accrued Income Taxes Current | 106.70 | 125.70 | 177.80 | 236.90 | 198.00 | 636.00 | 752.00 | 288.60 | NA | NA | NA | NA | NA | NA | NA | |
| Other Liabilities Current | 3504.70 | 3812.40 | 4426.30 | 4619.60 | 4631.30 | 4211.50 | 4845.80 | 4960.70 | NA | NA | 27.80 | NA | NA | NA | NA |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-06-28 | 2020-03-31 | 2020-03-29 | 2019-06-30 | 2019-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long Term Debt Noncurrent | 18724.50 | 19206.40 | 18762.50 | 19717.10 | 19854.30 | 20917.00 | 22102.20 | 22429.20 | NA | NA | 11385.20 | NA | NA | NA | NA | |
| Deferred Income Tax Liabilities Net | 2489.30 | 2617.90 | 2729.50 | 2815.00 | 2918.00 | 3485.70 | 3014.60 | 3123.70 | NA | NA | NA | NA | NA | NA | NA | |
| Other Liabilities Noncurrent | 1745.10 | 1814.20 | 1884.30 | 1933.60 | 2052.90 | 2241.90 | 2469.60 | 2483.10 | NA | NA | NA | NA | NA | NA | NA | |
| Operating Lease Liability Noncurrent | 179.30 | 192.20 | 191.70 | 200.90 | 213.70 | 208.60 | 217.20 | 229.50 | NA | NA | NA | NA | NA | NA | NA |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-06-28 | 2020-03-31 | 2020-03-29 | 2019-06-30 | 2019-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 19182.30 | 19805.40 | 20447.70 | 20492.70 | 21141.30 | 21206.90 | 21414.70 | 22954.10 | 12547.90 | 11746.20 | NA | 11262.70 | NA | NA | NA | |
| Common Stock Value | 12.10 | 12.10 | 12.10 | 12.10 | 12.10 | 12.10 | 12.10 | 12.10 | NA | NA | 0.00 | NA | 0.00 | NA | NA | |
| Additional Paid In Capital | 18616.80 | 18585.70 | 18555.10 | 18536.10 | 18514.10 | 18489.90 | 18464.60 | 18438.80 | NA | NA | -0.30 | NA | 0.00 | NA | NA | |
| Retained Earnings Accumulated Deficit | 4312.50 | 4106.80 | 3941.50 | 3688.80 | 4087.00 | 3909.90 | 4323.60 | 5361.20 | NA | NA | -0.90 | NA | 0.00 | NA | NA | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -3759.10 | -2899.20 | -2061.00 | -1744.30 | -1471.90 | -1205.00 | -1385.60 | -858.00 | -1423.80 | -2024.90 | 0.00 | -2453.50 | 0.00 | NA | NA | |
| Stock Issued During Period Value New Issues | 1.80 | 0.70 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 29.10 | 29.40 | 28.30 | 22.50 | 25.00 | 31.00 | 32.70 | 29.40 | 15.10 | 15.30 | NA | 19.40 | NA | NA | NA |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-06-28 | 2020-03-31 | 2020-03-29 | 2019-06-30 | 2019-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | 869.00 | 802.50 | 1138.50 | 523.10 | 1085.60 | 559.40 | 848.80 | 1230.80 | 1195.60 | 670.60 | 0.00 | 291.10 | 0.00 | 0.00 | 0.00 | |
| Net Cash Provided By Used In Investing Activities | -115.00 | -82.10 | -66.90 | -219.10 | -118.20 | -16.80 | 236.30 | 11111.90 | 11132.80 | -220.10 | -11411.60 | -145.60 | 0.00 | 0.00 | 0.00 | |
| Net Cash Provided By Used In Financing Activities | -758.70 | -779.60 | -1009.00 | -349.20 | -877.50 | -685.50 | -1099.80 | -12017.70 | -12166.40 | -609.10 | 11411.60 | -24.80 | 0.00 | 0.00 | 0.00 |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-06-28 | 2020-03-31 | 2020-03-29 | 2019-06-30 | 2019-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | 869.00 | 802.50 | 1138.50 | 523.10 | 1085.60 | 559.40 | 848.80 | 1230.80 | 1195.60 | 670.60 | 0.00 | 291.10 | 0.00 | 0.00 | 0.00 | |
| Depreciation Depletion And Amortization | 699.50 | 722.30 | 736.00 | 749.80 | 1017.10 | 1317.10 | 1422.50 | 953.10 | 432.30 | 415.70 | NA | 415.00 | NA | NA | NA | |
| Increase Decrease In Other Operating Capital Net | 130.60 | 136.90 | -132.70 | 266.90 | 306.10 | -261.10 | 354.60 | 130.20 | -131.60 | 30.40 | NA | -75.00 | NA | NA | NA | |
| Increase Decrease In Accounts Receivable | -241.20 | 26.80 | 115.50 | 9.80 | -183.80 | 54.90 | 59.80 | -106.00 | 149.90 | -49.00 | NA | -73.60 | NA | NA | NA | |
| Increase Decrease In Inventories | 169.50 | 201.00 | 69.10 | 76.50 | 10.10 | 137.60 | 203.40 | 209.50 | 256.60 | 144.00 | NA | 131.80 | NA | NA | NA | |
| Deferred Income Tax Expense Benefit | -21.90 | -104.80 | -52.80 | -52.90 | 147.00 | 293.20 | 288.40 | -161.20 | -90.70 | -75.80 | NA | -43.90 | NA | NA | NA | |
| Share Based Compensation | 29.10 | 29.40 | 28.30 | 22.50 | 25.00 | 31.00 | 32.70 | 29.40 | 15.10 | 15.30 | NA | 19.40 | NA | NA | NA |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-06-28 | 2020-03-31 | 2020-03-29 | 2019-06-30 | 2019-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Investing Activities | -115.00 | -82.10 | -66.90 | -219.10 | -118.20 | -16.80 | 236.30 | 11111.90 | 11132.80 | -220.10 | -11411.60 | -145.60 | 0.00 | 0.00 | 0.00 | |
| Payments To Acquire Property Plant And Equipment | 103.90 | 83.90 | 64.50 | 197.40 | 121.00 | 89.30 | 49.50 | 116.90 | 38.20 | 44.50 | NA | 43.40 | NA | NA | NA |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-06-28 | 2020-03-31 | 2020-03-29 | 2019-06-30 | 2019-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Financing Activities | -758.70 | -779.60 | -1009.00 | -349.20 | -877.50 | -685.50 | -1099.80 | -12017.70 | -12166.40 | -609.10 | 11411.60 | -24.80 | 0.00 | 0.00 | 0.00 |
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-06-28 | 2020-03-31 | 2020-03-29 | 2019-06-30 | 2019-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 4078.20 | 4116.80 | 4191.70 | 4341.60 | 4536.60 | 4577.80 | 4430.30 | 3623.50 | 2972.10 | 2731.20 | 0.00 | 2619.20 | 0.00 | 0.00 | 0.00 | |
| Revenue From Contract With Customer Excluding Assessed Tax | 4067.40 | 4105.40 | 4178.20 | 4331.30 | 4520.50 | 4561.70 | 4400.10 | 3587.70 | 2948.10 | 2695.90 | 0.00 | 2588.20 | 0.00 | 0.00 | 0.00 | |
| Operating, Developed Markets | 2431.50 | 2479.10 | 2476.10 | 2560.80 | 2655.90 | 2640.40 | 2571.60 | 2378.60 | 2163.20 | 1982.70 | NA | 1986.40 | NA | NA | NA | |
| Operating, Emerging Markets | 678.90 | 650.90 | 705.20 | 727.50 | 792.50 | 870.00 | 754.70 | 629.00 | 471.00 | 410.30 | NA | 343.50 | NA | NA | NA | |
| Operating, Greater China | 574.00 | 548.30 | 573.10 | 503.80 | 566.80 | 550.30 | 591.90 | 190.60 | 31.50 | 22.70 | NA | 15.10 | NA | NA | NA | |
| Operating, Japan Australia And New Zealand | 383.00 | 427.10 | 423.80 | 539.20 | 505.30 | 501.00 | 481.90 | 389.50 | 282.40 | 280.20 | NA | 243.20 | NA | NA | NA | |
| Foreign Exchange Contract, Cash Flow Hedging, Accumulated Net Gain Loss From Designated Or Qualifying Cash Flow Hedges | -32.20 | -28.10 | -14.20 | -11.00 | -10.20 | -3.60 | -6.10 | NA | -5.10 | 2.90 | NA | NA | NA | NA | NA | |
| Foreign Exchange Contract, Reclassification Out Of Accumulated Other Comprehensive Income, Accumulated Net Gain Loss From Designated Or Qualifying Cash Flow Hedges | -32.20 | -28.10 | -14.20 | -11.00 | -10.20 | -3.60 | -6.10 | -2.50 | -5.10 | 2.90 | NA | -0.10 | NA | NA | NA | |
| Foreign Exchange Contract, Reclassification Out Of Accumulated Other Comprehensive Income, Accumulated Other Comprehensive Income | -32.20 | -28.10 | -14.20 | -11.00 | -10.20 | -3.60 | -6.10 | -2.50 | -5.10 | 2.90 | NA | -0.10 | NA | NA | NA | |
| Amitiza | 39.40 | 44.10 | 41.80 | 54.00 | 49.50 | 52.10 | 45.90 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Brands | 2540.30 | 2483.10 | 2554.10 | 2611.90 | 2803.10 | 2701.70 | 2724.60 | 1859.00 | 1241.40 | 1073.00 | NA | 1061.50 | NA | NA | NA | |
| Celebrex | 82.20 | 85.90 | 85.20 | 87.10 | 86.00 | 82.30 | 89.00 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Complex G X And Biosimilars | 320.20 | 354.80 | 390.80 | 348.40 | 332.00 | 332.80 | 328.90 | 338.80 | 352.30 | 351.10 | NA | 253.30 | NA | NA | NA | |
| Creon | 76.40 | 75.40 | 74.70 | 85.10 | 81.10 | 80.70 | 69.90 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Dymista | 38.60 | 55.50 | 44.00 | 32.00 | 35.00 | 54.60 | 40.30 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Effexor | 64.20 | 73.70 | 77.50 | 44.70 | 79.50 | 83.50 | 76.60 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Epi Pen Auto Injectors | 114.40 | 106.50 | 88.80 | 54.40 | 129.50 | 104.10 | 103.70 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Generics | 1206.90 | 1267.50 | 1233.30 | 1371.00 | 1385.40 | 1527.20 | 1346.60 | 1389.90 | 1354.40 | 1271.80 | NA | 1273.40 | NA | NA | NA | |
| Influvac | 159.30 | NA | NA | 134.00 | 161.20 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Lipitor | 420.40 | 405.60 | 440.10 | 390.30 | 410.00 | 398.30 | 464.60 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Lyrica | 156.50 | 155.80 | 171.70 | 172.60 | 175.60 | 192.50 | 187.80 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Norvasc | 189.30 | 203.00 | 207.80 | 188.80 | 198.40 | 209.80 | 227.70 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Viagra | 117.00 | 115.10 | 129.80 | 121.40 | 138.00 | 134.80 | 139.60 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Xalabrands | 51.00 | 42.70 | 53.00 | 54.00 | 55.80 | 58.30 | 57.90 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Xanax | 38.30 | 37.20 | 40.00 | 44.40 | 47.60 | 48.80 | 45.10 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Yupelri | 53.40 | 49.10 | 43.70 | 49.90 | 39.40 | 41.80 | 36.90 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Zoloft | 53.10 | 62.50 | 73.10 | 101.00 | 61.30 | 70.90 | 76.60 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Brands, Developed Markets | 1327.70 | 1305.40 | 1298.70 | 1408.70 | 1522.70 | 1424.10 | 1403.70 | 1160.50 | 1013.20 | 855.50 | NA | 891.50 | NA | NA | NA | |
| Brands, Emerging Markets | 429.10 | 388.30 | 436.70 | 383.70 | 414.50 | 433.00 | 446.00 | 230.30 | 80.90 | 67.40 | NA | 64.70 | NA | NA | NA | |
| Brands, Greater China | 571.90 | 546.30 | 569.70 | 500.90 | 566.80 | 549.20 | 590.90 | 186.70 | 30.50 | 22.00 | NA | 14.70 | NA | NA | NA | |
| Brands, Japan Australia And New Zealand | 211.60 | 243.10 | 249.00 | 318.60 | 299.10 | 295.40 | 284.00 | 281.50 | 116.80 | 128.10 | NA | 90.60 | NA | NA | NA | |
| Complex G X And Biosimilars, Developed Markets | 295.00 | 327.00 | 364.10 | 315.20 | 305.10 | 309.30 | 312.00 | 306.60 | 325.80 | 328.60 | NA | 241.60 | NA | NA | NA | |
| Complex G X And Biosimilars, Emerging Markets | 14.10 | 15.40 | 16.40 | 18.40 | 13.70 | 13.70 | 8.00 | 14.10 | 18.10 | 14.00 | NA | 3.20 | NA | NA | NA | |
| Complex G X And Biosimilars, Greater China | 0.20 | 0.30 | NA | NA | NA | NA | NA | 0.50 | 0.10 | 0.00 | NA | 0.10 | NA | NA | NA | |
| Complex G X And Biosimilars, Japan Australia And New Zealand | 10.90 | 12.10 | 10.30 | 14.60 | 13.20 | 9.80 | 8.90 | 17.60 | 8.30 | 8.50 | NA | 8.40 | NA | NA | NA | |
| Generics, Developed Markets | 808.80 | 846.70 | 813.30 | 836.90 | 828.10 | 907.00 | 855.90 | 911.50 | 824.20 | 798.60 | NA | 853.30 | NA | NA | NA | |
| Generics, Emerging Markets | 235.70 | 247.20 | 252.10 | 325.40 | 364.30 | 423.30 | 300.70 | 384.60 | 372.00 | 328.90 | NA | 275.60 | NA | NA | NA | |
| Generics, Greater China | 1.90 | 1.70 | 3.40 | 2.70 | 0.00 | 1.10 | 1.00 | 3.40 | 0.90 | 0.70 | NA | 0.30 | NA | NA | NA | |
| Generics, Japan Australia And New Zealand | 160.50 | 171.90 | 164.50 | 206.00 | 193.00 | 195.80 | 189.00 | 90.40 | 157.30 | 143.60 | NA | 144.20 | NA | NA | NA |
